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Abstract
Purpose: Current evidence suggests that consumption of virgin olive oil (VOO) helps to protect 
against the development of atherosclerosis and that minor components such as oleanolic acid 
contribute to this effect.  In this study, the effects of triacylglycerol-rich lipoproteins (TRLs) derived 
from olive oil on inflammatory processes in macrophages and how they are modulated by oleanolic 
acid was investigated. 
Methods: TRLs isolated from healthy volunteers 2 and 4h after a test meal containing VOO, pomace 
olive oil (POO) (the second pressing of olive oil, enriched in minor components) or POO enriched with 
oleanolic acid (OPOO) were incubated with macrophages derived from the human monocyte cell line, 
THP-1. 
Results: All types of TRLs caused a decrease of about 50%  in the secretion of monocyte 
chemoattractant protein-1 (MCP-1) by the cells. Interleukin (IL)-6 secretion was also significantly 
decreased by 2 and 4h VOO TRLs and by 4 h OPOO TRLs. In contrast, increased IL-1β secretion 
was observed with all 2h TRL types, and increased tumour necrosis factor-α (TNF-α) production with 
2h VOO and POO, but not OPOO, TRLs. TRLs isolated after 4h, however, had no significant effects 
on TNF-α secretion and increased IL-1β secretion only when they were derived from VOO. 
Cyclooxygenase-2 (COX-2) mRNA expression was strongly down-regulated by all types of TRLs, but 
protein expression was significantly depressed only by 4h OPOO TRLs. 
Conclusion: These findings demonstrate that TRLs derived from olive oil influence inflammatory 
processes in macrophages and suggest that oleanolic acid may have beneficial effects. 




Triacylglycerol- rich lipoproteins (TRLs) are a heterogeneous mixture of lipoproteins, including 
chylomicrons, chylomicron remnants (CMR), very low density lipoproteins (VLDL) and VLDL remnants 
(intermediate density lipoproteins) found in the blood following a meal containing fat. Since the density 
of these lipoproteins overlaps considerably, the isolation of the single classes from postprandial 
human plasma is impractical, and the TRL fraction has been widely used to study the effects of 
dietary lipids on vascular disease [1]. 
Elevating circulating levels of TRLs postprandially have been identified as an independent risk factor 
for atherosclerosis [1-3]. Atherogenesis begins with endothelial dysfunction and invasion of the artery 
wall by activated leukocytes which then differentiate into macrophages and become lipid-engorged 
foam cells as they take up lipids from plasma lipoproteins [4]. Recent evidence suggests that TRLs 
have a direct influence on these events in addition to their indirect effects in increasing in the 
atherogenicity of the overall lipoprotein profile [5-7].  CMR and TRLs have been shown to enter the 
artery wall [8,9], and to be present in human atherosclerotic plaque [10,11],  and to cause leukocyte 
activation [5,12], endothelial dysfunction [13-15], and macrophage foam cell formation [13,16]. 
However, little information is available about the effects of TRLs on inflammatory processes in 
macrophages.
The Mediterranean diet is known to protect against atherosclerosis development, and the relatively 
high virgin olive oil (VOO) content is believed to be a contributory factor [17-19]. The cholesterol-
lowering effects of monounsaturated fatty acids (MUFA) a major component of VOO, are well 
established  [20,21], but recent studies have suggested that minor components of the unsaponifiable 
fraction of VOO, such as polyphenols, plant sterols, vitamins and carotenoids, may be responsible for 
some of its protective effects on the vasculature [21], including anti-inflammatory effects on the 
endothelium[22,23] and macrophages [24-26]. The triterpenoid, oleanolic acid,  is one such 
component and previous work has shown that it may modulate the immune response [22,27-30]. It 
has been found to inhibit the production of pro-inflammatory cytokines by human peripheral blood 
mononuclear cells [28] and to induce  prostaglandin I2 release by human coronary smooth muscle 
cells in a cyclooxygenase-2 (COX-2)-dependent manner [29].
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Pomace olive oil (POO) is produced from the second pressing of the olive skin, flesh and pit 
fragments (olive pomace) which is left after the extraction of VOO, and as a result it has an increased 
concentration of minor components, including oleanolic acid [26,31]. Like macronutrients such as fatty 
acids, lipophilic micronutrients such as oleanolic acid are carried from the gut to the liver in CMR, and 
thus have the opportunity to influence events in the vasculature during this process. The first aim of 
this study was to investigate the effects of TRLs derived from olive oil on inflammatory processes, 
including cytokine secretion and COX-2 expression, in macrophages, and the second aim was to 
establish how these effects may be modulated by the oleanolic acid content of the oil. TRLs were 
isolated from healthy volunteers after a meal containing VOO, POO or POO enriched with oleanolic 
acid (OPOO) and their effects on the secretion of the pro-inflammatory cytokines and on the 




Twelve healthy men (age 23.5±2.4y,body mass index (BMI) 23.2±1.3kg/m2) without a history of 
digestive or metabolic disorders and with fasting triacylglycerol (TG), cholesterol and glucose 
concentration, all within normal limits were recruited. All procedures followed were in accordance with 
Institutional and National ethical standards for human experimentation and with the Helsinki 
declaration of 1975 as revised in 2000. The volunteers gave written informed consent to a protocol 
approved by the Institutional Committee on Human Research (Hospital Universitario Virgen del Rocio, 
Seville, Spain). 
At 8am after an overnight fast, a baseline blood sample was taken from subjects via a catheter in the 
cubital vein. The test meal consisting of brown bread (71g) spread with 50g VOO, POO or OPOO 
(fatty acid/unsaponifiable fraction composition, Table 1) and skimmed yoghurt (125g) was then given 
Oleicola el Tejar S.A. (El Tejar, Spain) supplied the dietary oils and determined their minor component 
content.  Each subject consumed a test meal containing each of the three oils, with a 1week wash-out 
period between each test meal. The subjects were asked to refrain from consuming alcohol or 
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smoking 24h before each experiment. Blood samples were taken 2 and 4h postprandially. During this 
time the subjects were allowed to drink water and/or decaffeinated coffee ad libitum. 
TRL isolation and analysis
Serum was obtained from the blood samples by centrifugation (1700g, 20min, 12oC) and TRLs were 
isolated by ultracentrifugation as before [33]. Total lipids were extracted from TRL using 
chloroform:methanol (2:1 v/v) [32], dissolved in chloroform:methanol (2:1 v:v) and stored at -20oC 
prior to analysis. The lipid class, TG and phospholipid composition was determined by HPLC as 
described previously [33,34]. 
Culture of THP-1 macrophages
THP-1 monocytes (0.7-1.4 x 106 cells/ml) in RPMI 1640 supplemented with fetal bovine serum (10% 
v/v), penicillin (100U/ml), streptomycin (100mg/ml) and 2-mercaptoethanol (50µM) (culture medium) 
were differentiated into macrophages by incubation with PMA (200ng/ml) for 72h at 37°C in 5% 
CO2:95% air. Cell viability was >95% in all experiments and was unaffected by incubation with TRLs. 
Oil red O staining
Cells (0.7 x 106 cells/well) were incubated with TRLs (15µg cholesterol/ml) for 24h, washed with PBS 
and 60% propan-2-ol, then Oil red O (0.5% (w/v) in 40% propan-2-ol/H2O (v/v)) was added. After 
15min, the stain was removed and cells were washed twice with PBS. Staining density was quantified 
using Biorad Quantity One software.
Assay of cytokine secretion
THP-1 macrophages (0.7 x 106 cells/well) were incubated with TRLs (15µg cholesterol/ml) for 16h. The 
concentration of IL-1β, IL-6, TNF-α, and MCP-1 in the medium was determined by ELISA according to 
manufacturers’ instructions. 
mRNA analysis
THP-1 macrophages (0.7 x۬ 106 cells/well) were incubated with TRLs (15 µg cholesterol/ml) for 16 h 
and total RNA was then extracted (RNAeasy Plus MiniKit, Qiagen, Crawley, UK) with DNAase I 
treatment according to manufacturers’ instructions. Omniscript reverse transcriptase and oligo-(dT) 
5
(Qiagen) was used for reverse transcription, and mRNA abundance for COX-1, COX-2, iNOS and the 
housekeeping gene β-2-microglobulin were determined by real time polymerase chain reaction 
(qPCR) using SYBR green quantitative fluorescence and an Opticon 2 LightCycler system (MJ 
Research, Waltham, Massachusetts, USA). Four candidate housekeeping genes, β-2-microglobulin 
glyceraldehyde phosphate dehydrogenase, β-actin and ribosomal protein L13a were tested under the 
experimental conditions used, and β-2-microglobulin was selected as it showed no changes. The 
forward and reverse primers and the PCR conditions employed are shown in Supplementary (S) 
Table 1. Ct values were determined by automated threshold analysis (Opticon Monitor 2 software). 
Data were normalised using values obtained for β-2-microglobulin and the fold change in mRNA 
expression in TRL-treated as compared to control macrophages was determined by the method of 
Pfaffl [35].  
Immunoblotting
THP-1 macrophages (1.4 x 106 cells/well) were incubated with TRLs (15µg cholesterol/ml, 30min) 
prior to incubation with LPS (1µg/ml) for 16h. Cells were then lysed by the addition of 100-250µl lysis 
buffer (76.5mM Tris (pH 6.8), 10% glycerol, 2% sodium dodecyl sulphate (SDS), 200mM sodium 
orthovanadate, 10mg/ml protease inhibitor) for 5min at 4oC. Lysates were heated to 100oC (5min), 
centrifuged at 9000g (10min),mixed with sample buffer (240mM Tris (pH 6.8), 40% glycerol, 8% SDS 
and 0.04% bromophenol blue (2:1, v:v)), and β-mercaptoethanol (1% final concentration) was then 
added. After heating to 100oC (5min) treated lysates were electrophoresed in running buffer (25mM 
Tris, 0.192M glycine and 0.1% (w/v) SDS) (80mA, 1h). Proteins were wet transferred onto 
polyvinylidene fluoride membranes (Bio-Rad (Hemel Hempstead, UK), blocked with 5% milk in Tris 
buffered saline (0.1% Tween) (TBST) (1h), washed in 0.1% TBST (6 x 10min) and incubated with 
COX-1 or COX-2 primary antibodies (Cell Signalling Technology, Hitchin, Herts, UK) (1:1000 v/v) in 
0.1% TBST containing 10% BSA (4oC overnight). After washing with 0.1% TBST (6 x 10min), 
membranes were incubated with anti-rabbit antibodies conjugated with horseradish protein 1:10,000 
(v:v) in 0.1% TBST containing 0.2% BSA for 1h. Immunoreactive proteins were detected using 
enhanced chemiluminescence (GE Health Care, Bucks, UK). 
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Statistical analysis
Data were analysed by one-way or two-way ANOVA followed by Dunnett’s or Bonferroni’s multiple 
comparison test as appropriate.
Results
Lipid and fatty acid composition of VOO, POO and OPOO oils and TRLs 
The fatty acid and unsaponifiable composition of VOO, POO and OPOO is shown in Table 1. There 
were no significant differences between the fatty acid composition of the three test oils, however, 
there were important differences in the minor component composition. Oleanolic acid was 
undetectable in VOO, but present in POO ( 32.2mg/kg) and in OPOO at a higher level (574.9mg/kg) 
by supplementation. VOO also lacked fatty alcohols, while POO and OPOO contained almost 
3,500mg/kg. In addition, the sterol and tocopherol content was considerably higher in POO and 
OPOO as compared to VOO. 
The lipid composition of TRLs was not affected by the type of oil consumed, with TG being the 
predominant lipid at both 2 and 4h (Figure 1). The fatty acid composition of the TG fraction of the 
TRLs isolated 2h and 4h after consumption of the three test meals was generally similar to that of the 
parent oils. Oleic acid (18:1 n-9 cis) was the main fatty acid in all TRL types (42-49%) (STable 2), with 
no significant differences between those derived from VOO, POO or OPOO or between the two time 
points. Other major fatty acids present were palmitic acid (16:0) (17-19%), stearic acid (7-12%) and 
linoleic acid (18:2 n-6) (15-18%) and their proportions were not significantly different between the diet 
groups or the 2 and 4h time points. MUFA (>95% oleic acid) accounted for 48-54% of the total TG 
fatty acid content in all TRL types, while 26-32% was saturated fatty acids (SFA) and 21-25% 
polyunsaturated fatty acids (PUFA) (STable 3).
As expected, the fatty acid profile of the PL fraction of the TRLs did not resemble that of the parent oil 
as closely as the TG fraction. In addition to oleic acid (15-21%), the other main fatty acids present 
were palmitic acid (22-25%), stearic acid (20-27%) and linoleic acid (14-18%), and there were also 
significant amounts of 20:3 (n-6) (5-7%), arachidonic (20:4, n-6) (2.4-3.6%)and docosahexaenoic 
(22:6, n-3) (2.2-2.5%) acids present. The proportions of all fatty acids were similar in TRLs derived 
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from all the test oils and isolated at 2 and 4h (data not shown). Thus, SFA (46-55% total fatty acids) 
predominated in the PL fraction of all TRLs, followed by PUFA (29-35%), while MUFA accounted for 
18-25% (STable 3). 
Induction of lipid accumulation in macrophages by TRLs
TRLs isolated 2h after consumption of the test meal had no significant effect on the amount of lipid 
accumulation observed by Oil Red O staining. In contrast, TRLs isolated after 4h caused an increase 
intracellular lipid levels of approximately 2 fold (P<0.001), regardless of the oil from which they were 
derived.
The effect of TRLs on chemokine/cytokine secretion by macrophages
Secretion of MCP-1, was markedly decreased by about 50% by all TRL types, and there were no 
differences between the effects of those derived from different oils or isolated at 2 or 4h (VOO, POO 
both time points, P<0.001; OPOO, 2h P<0.001, 4h P<0.01) (Figure 3A). IL-6 secretion was also 
decreased by 2h TRLs, but this change only reached significance in the case of VOO (-54%, P<0.05) 
(Figure 3B). Similar decreases were observed with TRLs isolated after 4h, with those derived from 
VOO (-62.5%, P<0.05) and OPOO (-54%, p<0.05) causing significant changes. In contrast, TNF-α 
secretion, was significantly increased by VOO (+ 63%, P<0.05) and POO (+ 83%, P<0.01), but not 
OPOO, TRLs isolated after 2h, but in this case there was a clear difference between the effects of 
particles isolated at the two different time points, since 4h TRLs had no significant effects regardless 
of the test oil consumed (Figure 3C).  All three types of TRLs isolated after 2h also increased the 
secretion of IL-1β by the cells (+ 46-55%; VOO, OPOO, P<0.05; POO P<0.01), but with 4h TRLs this 
effect was significant only when the test meal included VOO (+47%, P<0.05) (Figure 3D). Production 
of the anti-inflammatory cytokine, TGF-β, was not affected by any of the three TRL types from either 
time point of isolation (Figure 3E).
The effects of TRLs on the expression of COX-2 and iNOS by macrophages 
The abundance of COX-2 mRNA was decreased after incubation  with all three TRL types, and this 
effect was particularly marked with 4h TRLs derived from OPOO (2h TRLs, -63-70%; 4h TRLs, VOO, 
-63%, POO, -71%, OPOO, -84%; P<0.001 in all cases) (Figure 4A). In contrast, COX-1 mRNA levels 
8
were not significantly changed in any conditions (Figure 4B). In addition, TRLs caused no significant 
changes in iNOS mRNA levels regardless of the test oil used or the time 
of isolation (Figure 4C).
COX-2 protein was undetectable by immunoblotting in untreated macrophages, but became apparent 
after pre-incubation with LPS (1µg/ml). Experiments with TRLs, therefore, were carried out following 
pre-incubation of the cells with LPS and COX-1 and COX-2 protein expression was assessed by 
immunoblotting (Figure 5). As expected, COX-1 protein levels were not significantly changed by 
treatment with TRLs (sample:control ratio; 2h, VOO 0.84+0.04, POO 1.02+0.24, OPOO 0.99+0.13; 4h, 
VOO 1.38+0.54, POO 1.39+0.45, OPOO 0.85+0.09), allowing it to be used as a housekeeping gene for 
normalisation of COX-2 protein levels. In contrast to the marked decrease observed in COX-2 mRNA 
abundance, protein concentrations (Figure 5A-C) showed a significant decrease only with 4h TRLs 
derived from OPOO (Figure 5C). 
Discussion
Current evidence suggests that TRLs promote inflammatory processes by increasing pro-
inflammatory cytokines, adhesion molecules and ROS production and expression within the vessel 
wall [36-38], but that those derived from an olive oil-rich diet have a less inflammatory effect 
compared to TRLs derived from butter, vegetable oil or fish oil [39-41]. Little is known, however, about 
the effects of TRLs on inflammatory processes in macrophages.
To investigate the effects of TRLs derived from olive oil on macrophage inflammatory processes and 
how they may be modified by changes in the content of the lipophilic minor component oleanolic acid, 
we used THP-1 macrophages and lipoproteins isolated 2 or 4h after consumption of a test meal 
containing VOO, POO or OPOO, three oils with a similar fatty acid composition (Table 1), but differing 
in their content of minor components, and in particular, oleanolic acid (OPOO). Analysis of the lipid 
classes present in the TRLs and their fatty acid composition demonstrated that there were no 
significant differences between those derived from VOO, POO or OPOO (Figure 1, STables 2,3). 
Thus, any differences in the effects of TRLs derived from the three different oils are likely to be due to 
differences in their content of minor components.
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Previous studies have demonstrated that TRLs isolated postprandially [42] or obtained from 
hypertriglyceridemic subjects [43] induce macrophage foam cell formation. In the present study, TRLs 
isolated 4h following consumption of the test meals were found to cause a 2 fold increase in lipid 
accumulation in THP-1 macrophages, while TRLs isolated after 2h had no significant effect (Figure 2). 
These results are consistent with the findings of Palmer et al. [42], who used TRLs isolated 5h 
postprandially, and indicate that the induction of foam cell formation by TRLs is dependent on the time 
at which they are recovered. TRLs isolated 2h after consumption of a fat meal are likely to contain a 
higher proportion of chylomicrons, which are not taken up well by macrophages, while those 
recovered after 4h would be expected to contain a higher proportion of CMR [1,7] which are taken up 
more easily, resulting in foam cell formation.
TRLs have been found to influence inflammatory processes in the vasculature by increasing 
leukocyte activation [5,12,36], modulating endothelial cell function [14], increasing vascular sensitivity 
[36,44] and decreasing the expression of genes involved in smooth muscle cell proliferation and 
inflammation [39]. Previous work has demonstrated that the secretion of the pro-inflammatory 
chemokine/cytokines, MCP-1, TNF-α, IL-6 and IL-1β by macrophages is down-regulated by CMR , 
while secretion of the anti-inflammatory cytokine, TGF-β, is unaffected [45,46]. The current study 
indicates that TRLs also down-regulate MCP-1 and IL-6 production by the cells, while having no effect 
on TGF-β secretion (Figure 3A,B,E). In contrast to the findings with  CMR, however, TRLs were 
shown to increase macrophage TNF-α and IL-1β secretion when they were isolated 2h postprandially, 
although the effect on TNFα was abolished when they were obtained after 4h (Figure 3C). Thus, 
these findings support the idea that CMRs have anti-inflammatory effects on macrophages, but 
suggest that in vivo other TRLs present postprandially such as chylomicrons and VLDL may modulate 
the cellular response. 
COX-2 and iNOS are inducible enzymes that have been implicated in inflammatory pathways and 
diseases, including atherosclerosis. Induction of the expression of iNOS during inflammation 
contributes to endothelial dysfunction [47], but we found no evidence for a role for TRLs in the 
regulation of iNOS expression (Figure 4C). COX enzymes catalyse the formation of prostaglandins. 
COX-1 is expressed constitutively in most cells, including macrophages, but  the expression of COX-2 
is  induced during inflammation by many mediators including cytokines such as IL-1β and TNF-α [48]. 
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COX-2 levels have been found to be upregulated in atherosclerotic lesions [48]. The present study 
shows that all types of TRLs markedly decreased macrophage COX-2 mRNA expression (Figure 4A), 
while, as expected, that of the constitutively expressed COX-1 was unaffected (Figure 4B). COX-2 
protein levels also tended to decrease, although in this case significance was reached only in the 
case of OPOO TRLs isolated 4h postprandially (Figure 5C). These findings are consistent with our 
previous work which demonstrated that CMR down-regulate COX-2 mRNA expression and that this 
effect may be mediated by suppression of the activity of nuclear factor-κB [45]. Down-regulation of 
COX-2 expression is usually considered to be atheroprotective, since it reduces inflammatory 
prostaglandin production. However, Chan et al. [49] have reported that COX-2 inhibition in 
macrophages caused enhanced foam cell formation, and other studies have suggested that it may 
adversely affect platelet function by causing an imbalance between thromboxanes and prostaglandins 
[50]. The suppression of COX-2 induction by TRLs, therefore, is likely to be anti-inflammatory, but 
may have other less beneficial effects.
Although, in general, the effects of TRLs isolated following the three test diets had quantitatively 
similar effects, unlike VOO and POO TRLs, OPOO TRLs did not cause a significant rise in TNF-α 
secretion (Figure 3C) by macrophages when isolated after 2h, or in IL-1β secretion when isolated 
after 4h (Figure 3D). Furthermore, COX-2 protein expression was significantly decreased in cells 
treated with 4h TRLs derived from OPOO, but not VOO or POO, as compared untreated controls 
(Figure 5C), which corresponded to a stronger down-regulation of  COX-2 mRNA expression (Figure 
4A). Thus, these results provide only limited support for previous findings suggesting that oleanolic 
acid may have an anti-inflammatory effect on vascular cells, and further work is needed before 
definitive conclusions can be drawn [23-28].
In summary, the work presented here demonstrates that TRLs derived from olive oil cause foam cell 
formation and modulate some of the inflammatory processes in macrophages that are involved in the 
pathogenesis of atherosclerosis. The particles had both inflammatory (increased TNF-α and IL-1β 
secretion) and anti-inflammatory (decreased MCP-1 and IL-6 secretion, decreased COX-2 
expression) effects. However, TRLs isolated 4h postprandially, and therefore likely to contain a higher 
proportion of remnant  particles, were less inflammatory than those isolated after 2h, although they 
caused greater lipid accumulation in the cells. 
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Table 1
Fatty acid and unsaponifiable fraction composition of VOO, POO and OPOO parent oils
Data are expressed as % total fatty acids or mg/kg (unsaponifiable fraction); ND not detected. 







16.0 9.75 9.46 9.53
16.1 n-9 0.11 0.12 0.12
16.7 n-7 0.61 0.65 0.65
18.0 3.11 3.33 3.35
18.1 n-9 76.31 74.25 74.39
18.1 n-7 2.95 3.14 3.08
18.2 n-6 6.00 7.75 7.77
18.3 n-3 0.37 0.61 0.42
20.0 0.68 0.61 0.60




Squalene 2643 2543 2543
Sterols 1558 2245 2245
Tocopherols 172.3 981.2 981.2
Oleanolic acid ND 32.2 574.9




Lipid classes composition of TRL obtained from blood samples taken from volunteers 2h (A) or 4h (B) 
after the intake of a test meal containing VOO, POO or OPOO. CE, cholesterol esters; FC, free 
cholesterol; TC, total cholesterol. Data shown are the mean from  9 (VOO, 2h), 10 (4h all oils) or 11 
(POO and OPOO, 2h) subjects and error bars show the SEM
Figure 2
TRLs (15μg cholesterol/ml) obtained from blood samples taken from volunteers 2h or 4h after a test 
meal containing VOO, POO or OPOO or an equal volume of saline (Control) were incubated with 
THP-1 macrophages for 24h. Cells were then stained with Oil red O and staining was quantified by 
density analysis. Data shown are the mean from 3 subjects and error bars show the SEM. ***P<0.001 
vs Control 
Figure 3
TRLs (15μg cholesterol/ml) obtained from blood samples taken from volunteers 2h or 4h after a test 
meal containing VOO, POO or OPOO or an equal volume of saline (Control)  were incubated with 
THP-1 macrophages for 16 h. Cell culture media was analysed for MCP-1 (A), IL-6 (B), TNF-α (C), IL-
1β (D)  and TGF-β (E) by ELISA. Data shown are the mean from 5-12 separate experiments each 
using TRLs from different subjects, except for TGF-β and 4h VOO TRLs (n = 4) and OPOO TRLs (n = 
3). Error bars show the SEM. *P<0.05, **P<0.01, ***P<0.001 vs Control
Figure 4
TRLs (15μg cholesterol/ml)  obtained from blood samples taken from volunteers 2h or 4h after a test 
meal containing VOO, POO or OPOO or an equal volume of saline (Control) were incubated with 
THP-1 macrophages for 16h.  and  the abundance of mRNA transcripts for A. COX-2; B. COX-1 and 
C: iNOS was determined by qPCR. Data shown are the mean from 8 (COX-2, Control; iNOS, Control; 
18
COX-1, OPOO), 9 (iNOS OPOO), 10 (COX-2, all TRL types; COX-1, VOO TRLs) or 11 (COX-1, POO 
TRLs; iNOS, VOO, POO) separate experiments each using TRLs from different subjects. *** p<0.001 
vs. Control. 
Figure 5
TRLs (15μg cholesterol/ml)  obtained from blood samples taken from volunteers 2h or 4h after a test 
meal containing VOO, POO or OPOO or an equal volume of saline (Control) were incubated with 
THP-1 macrophages for 16h after prior incubation with LPS (1µg/ml) for 30 min.  Cells were lysed and 
COX-1 and COX-2 protein concentrations were assessed by immunoblotting. A, B: representative 
blots for 2h and 4h samples, respectively. C: Band density was quantified using Quantity One 
software, data for COX-2 were normalised using values for COX-1 and expressed as a percentage of 
the Control values. Data shown are the mean from 9 (except 4h POO TRLs, where n = 10) separate 
experiments each using TRLs from a different subject. Error bars show the SEM. *P<0.05 vs Control. 
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